Sigma Labs Announces Full Year 2018 Financial Results


Sigma Labs, Inc.
Condensed Statements of Cash Flows
For the Periods Ended
(Unaudited)

			December 31,			December 31,
				2018			2017
OPERATING ACTIVITIES
	Net Loss		$	(5,574,163	)	$	(4,424,503	)

	Adjustments to reconcile Net Income (Loss) to Net Cash used in operating activities:
	Noncash Expenses:
		Depreciation and Amortization		192,374			196,943
		Stock Based Compensation		1,145,530			719,796
		Loss on Writeoff of Assets		36,733			13,161
		Refund on Write-off of Asset		-			15,700
		Gain/Loss on Change in Derivative Balance		-			186,908
		Original Issue Discount Amortization		-			88,442
		Debt Discount Amortization		-			358,280
	Change in assets and liabilities:
		Accounts Receivable, net		65,738			183,698
		Interest Receivable		34,390			-
		Inventory		(24,844	)		(5,464	)
		Prepaid Assets		(1,652	)		(16,957	)
		Accounts Payable		116,604			(11,291	)
		Deferred Revenue		15,818			32,365
		Accrued Expenses		230,501			24,529
		NET CASH USED IN OPERATING ACTIVITIES	$	(3,762,971	)	$	(2,638,393	)

INVESTING ACTIVITIES
		Purchase of Furniture and Equipment		(79,116	)		(69,463	)
		Purchase of Intangible Assets		(149,409	)		(70,997	)
		Notes Receivable		632,197			(788,500	)
		NET CASH PROVIDED (USED) BY INVESTING ACTIVITIES		403,672			(928,960	)

FINANCING ACTIVITIES
		Proceeds from issuance of Series B Convertible Preferred & Warrants		1,000,000			-
		Proceeds from issuance of Series C Convertible Preferred & Warrants		350,000			-
		Proceeds from issuance of Common Stock and Warrants		2,040,100			5,823,300
		Less Offering Costs		(443,700	)		(750,664	)
		Payments on Notes Payable		-			(500,000	)
		Proceeds from Exercise of Warrants		192,132			112,000
		Dividends on Preferred		(15,125	)		-
		NET CASH PROVIDED BY FINANCING ACTIVITIES		3,123,407			4,684,636		153,013

NET CASH INCREASE (DECREASE) FOR PERIOD			$	(235,892	)	$	1,117,283

CASH AT BEGINNING OF PERIOD			$	1,515,674		$	398,391

CASH AT END OF PERIOD			$	1,279,782		$	1,515,674

Supplemental Disclosures:
	Noncash investing & financing activities disclosure:
		Write-off of Derivative Liability	$	-		$	(280,114	)
		Conversion of conv debt for stock	$	(50,000	)	$	(408,566	)
	Ot her noncash operating activities disclosure:
		Issuance of Common Stock for Services	$	256,264		$	75,578
	Di sclosure of cash paid for:
		Interest	$	12,205		$	89,348

« Previous Page 1 | 2 | 3 | 4 | 5 Next Page »